Novo Nordisk A/S: Company Events Publications and Financial Calendar | NOVO B | DK0062498333

Chart calendar Novo Nordisk A/S

b8462.JGxjG7hLbuZaIDo0RjnibrZ5o9j7ZKrWW1U9CdoiAm4.ewcncfdyA7MrTw4CKg6QBdIK6rutAPWSDQVPVoJLVQESKVp89nIenhETcw~c32d24ab0c1a6bc5cca8bd469ed09a43

Upcoming events on Novo Nordisk A/S

2026-02-03	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-04-29	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-05	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-03	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2027-02-02	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Novo Nordisk A/S

2026-01-13	JP Morgan Healthcare Conference
2025-11-14	Extraordinary Shareholders Meeting
2025-11-10	American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0174
2025-11-10	American Association for the Study of Liver Diseases Meeting - Poster No:4042
2025-11-10	American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0010
2025-11-09	American Association for the Study of Liver Diseases Meeting - Oral Presentation No:0148
2025-11-09	American Association for the Study of Liver Diseases Meeting - Poster No:3086
2025-11-08	American Association for the Study of Liver Diseases Meeting - Poster No:2625
2025-11-08	American Association for the Study of Liver Diseases Meeting - Poster No:2545
2025-11-08	American Association for the Study of Liver Diseases Meeting - Poster No:2075
2025-11-08	American Association for the Study of Liver Diseases Meeting - Poster No:2570
2025-11-08	American Association for the Study of Liver Diseases Meeting - Poster No:2052
2025-11-06	ObesityWeek - Semaglutide 7.2 mg
2025-11-06	ObesityWeek - ASCVD Risk
2025-11-06	Q3 2025 Earnings Call - London
2025-11-05	ObesityWeek - World Risk of CV
2025-11-05	ObesityWeek - Semaglutide 2.4 mg
2025-11-05	ObesityWeek - Cardiovascular Risk
2025-11-05	ObesityWeek
2025-11-05	ObesityWeek

Past dividends on Novo Nordisk A/S

2025-08-14	Interim Payment 3.75 DKK
2025-03-27	Final Payment 7.9 DKK
2024-08-14	Interim Payment 3.5 DKK
2024-03-21	Final Payment 6.4 DKK
2023-08-17	Interim Payment 6 DKK
2023-03-23	Final Payment 8.15 DKK
2022-08-11	Interim Payment 4.25 DKK
2022-03-24	Final Payment 6.9 DKK
2021-08-15	Interim Payment 3.5 DKK
2021-03-25	Final Payment 5.85 DKK
2020-08-13	Interim Payment 3.25 DKK
2020-03-26	Final Payment 5.35 DKK
2019-08-15	Interim Payment 3 DKK
2019-03-21	Final Payment 5.15 DKK
2018-08-16	Interim Payment 3 DKK
2018-03-22	Final Payment 4.85 DKK
2017-08-17	Interim Payment 3 DKK
2017-03-23	Final Payment 4.6 DKK
2016-08-11	Interim Payment 3 DKK
2016-03-20	Annual 6.4 DKK

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million DKK	Released Forecast Spread	176 954 175 090 1.06%	232 261 228 920 1.46%	290 403 285 429 1.74%	307 570	305 219	330 020
EBITDA Million DKK	Released Forecast Spread	82 171 82 386 -0.26%	111 987 109 530 2.24%	147 446 141 939 3.88%	148 784	145 748	158 831
EBIT Million DKK	Released Forecast Spread	74 809 75 141 -0.44%	102 574 101 255 1.3%	128 339 126 210 1.69%	128 591	127 490	138 975
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	69 062 69 370 -0.44%	104 674 102 184 2.44%	127 191 125 432 1.4%	130 989	127 432	137 972
Net income Million DKK	Released Forecast Spread	55 525 54 785 1.35%	83 683 82 021 2.03%	100 988 100 215 0.77%	103 096	99 765	108 221
EPS DKK	Released Forecast Spread	12,2 12,2 0.25%	18,6 18,3 1.79%	22,6 22,3 1.67%	23,1	22,6	24,3
Announcement Date		01/02/23	31/01/24	05/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million DKK	Released Forecast Spread	65 349 63 437 3.01%	68 060 68 563 -0.73%	71 311 71 869 -0.78%	85 683 80 179 6.86%	78 087 78 019 0.09%	76 857 77 114 -0.33%	74 976 77 075 -2.72%	76 875	72 861	76 046	77 149	83 172
EBITDA Million DKK	Released Forecast Spread	34 760 31 300 11.05%	34 779 29 430 18.17%	35 972 36 184 -0.59%	41 935 36 501 14.89%	42 621 40 715 4.68%	38 282 38 965 -1.75%	31 439 34 245 -8.19%	39 048	35 260	36 385	36 150	35 882
EBIT Million DKK	Released Forecast Spread	31 846 28 694 10.99%	25 934 27 258 -4.86%	33 822 33 301 1.57%	36 737 32 939 11.53%	38 791 36 740 5.58%	33 449 34 694 -3.59%	23 682 24 684 -4.06%	31 428	30 574	31 698	31 463	30 014
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	31 918 28 630 11.48%	25 332 27 740 -8.68%	34 384 33 325 3.18%	35 557 31 943 11.31%	37 033 35 000 5.81%	33 805 34 568 -2.21%	25 517 26 943 -5.29%	34 016	32 338	32 009	30 770	28 106
Net income Million DKK	Released Forecast Spread	25 407 23 169 9.66%	20 050 22 116 -9.34%	27 301 26 877 1.58%	28 230 25 743 9.66%	29 034 27 298 6.36%	26 503 27 136 -2.33%	20 006 21 390 -6.47%	26 656	25 231	25 382	25 692	25 518
EPS DKK	Released Forecast Spread	5,68 5,19 9.54%	4,49 4,71 -4.72%	6,12 5,98 2.32%	6,34 5,76 10.06%	6,53 6,15 6.1%	5,96 6,07 -1.87%	4,50 4,59 -1.91%	5,89	5,68	5,72	5,79	5,73
Announcement Date		02/05/24	07/08/24	06/11/24	05/02/25	07/05/25	06/08/25	05/11/25	-	-	-	-	-

Upcoming sector events for Novo Nordisk A/S

2026-01-20	DR. REDDY'S LABORATORIES LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-20	HANALL BIOPHARMA CO., LTD.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	JOHNSON & JOHNSON	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-21	ALIVUS LIFE SCIENCES LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-21	TORRENT PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-22	LAURUS LABS LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-22	GRANULES INDIA LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-27	GLAND PHARMA LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-27	JCR PHARMACEUTICALS CO., LTD.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-27	PIRAMAL PHARMA LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Novo Nordisk A/S

2026-01-16	J. B. CHEMICALS & PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release
2026-01-15	SUPRIYA LIFESCIENCE LIMITED	Q3 2026 Earnings Release (Projected)
2026-01-12	LOTUS PHARMACEUTICAL CO., LTD.	December 2025 Sales and Revenue Release
2026-01-10	SCINOPHARM TAIWAN, LTD.	December 2025 Sales and Revenue Release
2026-01-09	CALIWAY BIOPHARMACEUTICALS CO., LTD.	December 2025 Sales and Revenue Release
2026-01-08	BORA PHARMACEUTICALS CO., LTD.	December 2025 Sales and Revenue Release
2026-01-08	TILRAY BRANDS, INC.	Q2 2026 Earnings Release
2026-01-08	CENTER LABORATORIES, INC.	December 2025 Sales and Revenue Release
2026-01-07	TTY BIOPHARM COMPANY LIMITED	December 2025 Sales and Revenue Release
2026-01-05	HISAMITSU PHARMACEUTICAL CO., INC.	Q3 2025 Earnings Release